Skip to main content

In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure


Permanent middle cerebral artery (MCA) occlusion (pMCAO) by electrocoagulation is a commonly used model but with potential traumatic lesions. Early MRI monitoring may assess pMCAO for non-specific brain damage. The surgical steps of pMCAO were evaluated for traumatic cerebral injury in 22 Swiss mice using diffusion and T2-weighted MRI (7T) performed within 1 h and 24 h after surgery. Temporal muscle cauterization without MCA occlusion produced an early T2 hyperintensity mimicking an infarct. No lesion was visible after temporal muscle incision or craniotomy. Early MRI monitoring is useful to identify non-specific brain injury that could hamper neuroprotective drugs assessment.


Investigating cerebral ischemia requires animal models relevant to human stroke. A precise knowledge of the strengths and shortcomings of available models is mandatory for effective research in neuroprotection [1, 2]. Initially described in the rat [3] and subsequently adapted in mice [4], permanent middle cerebral artery (MCA) occlusion (pMCAO) by electrocoagulation is a widely used model of focal ischemia. Invasive surgical procedures are required: temporal muscle dissection, in some cases by electrical cauterization [5, 6], subtemporal craniotomy and MCA electrocoagulation. This model, by interrupting blood flow at the level of the parietal cerebral artery branch of the MCA (distal occlusion), has the advantage of producing smaller, cortical-restricted, more reproducible and better-tolerated infarcts compared to suture MCAO, which endoluminal occluder is situated in the internal artery, at the birth of the MCA (proximal occlusion) and gives rise to extensive cortico-striatal infarcts [7, 8]. It may however induce traumatic brain damage.

To our knowledge, sham-operated animals have only been studied using immunohistology at the subacute stage of cerebral ischemia. Early monitoring with magnetic resonance imaging (MRI) may facilitate in vivo identification of traumatic brain injury during pMCAO.

Materials and methods

Animals and surgical procedure

We designed an analytic appraisal of pMCAO procedure which included two methods of temporal muscle dissection: cauterization and blade incision. After intraperitoneal anesthesia with 12 mg/Kg xylazine and 90 mg/Kg ketamine, 22 male Swiss mice (28-30 g, Charles River, France) were allotted as follows:

  • group A (n = 6): temporal muscle cauterization without craniotomy nor MCA occlusion;

  • group B (n = 4): temporal muscle incision without craniotomy nor MCA occlusion;

  • group C (n = 4): temporal muscle incision followed by craniotomy without MCA occlusion;

  • group D (n = 6): temporal muscle incision followed by craniotomy and MCA electrocoagulation;

  • group E (n = 2): temporal muscle cauterization followed by craniotomy and MCA electrocoagulation.

Craniotomy and MCA electrocoagulation were performed as previously described [9]. Whatever the group be, surgery was performed in less than 15 min.


MRI experiments were performed on a 7T/12 cm magnet (Bruker BioSpin GmbH, Ettlingen, Germany) using a 72 mm inner diameter birdcage for RF transmission and a 15 mm diameter surface coil for reception. T2-weighted images (T2WI) were acquired using a RARE sequence with TE/TR = 75/3000 ms. Diffusion weighted spin-echo images (DWI) were acquired with a TE/TR = 14/2000 ms using 2 b-values (139 and 1061 s/mm2). Apparent diffusion coefficients (ADC, in mm2/s) were calculated by fitting a monoexponential model function on a pixel-by-pixel basis. The field of view was 20 × 20 mm2 and slice thickness 1.0 mm. For T2WI, 15 slices were acquired with 256 × 256 matrix and for DWI, 7 slices with 128 × 128 matrix. Mice anesthesia was maintained during the MRI with isofluorane (1.5% in air). Body temperature was kept at 37 ± 1°C with an integrated heating system, and a pressure probe monitored mice respiration. MRI was started immediately following the end of surgical procedure and all MR acquisitions were performed between 30 min and 60 min after the start of surgery. MRI was repeated on day 1.


Temporal muscle cauterization in the absence of MCA electrocoagulation (group A) consistently produced an extensive lesion across the frontoparietal cortex (n = 6/6). These lesions appeared hyperintense on T2WI within the first hour after surgery, with an early mass effect and reduced ADC (Figure 1A). Temporal muscle incision and craniotomy in the absence of MCA electrocoagulation (group B and C, respectively) caused no visible brain injury on day 0 or day 1 MRI (n = 4/4 in groups B and C, Figure 1B and 1C). MCA electrocoagulation (group D) induced an ischemic lesion in the frontoparietal cortex with reduced ADC on day 0 (n = 6/6). These lesions were not visible on T2WI within 1 h post-surgery (Figure 1D). No bleeding was noted during the surgery, but MCA electrocoagulation occasionally produced a small superficial traumatic lesion (n = 2/6 in group D, figure 1D). When pMCAO was performed using temporal muscle cauterization (group E), the lesion appeared as a superimposition of the almond-shaped cauterization lesion and of the MCA-territory bounded ischemic lesion (n = 2/2, Figure 2). Infarcts from group A, D and E were clearly delineated on day 1 T2WI.

Figure 1
figure 1

MRI within one hour of surgery: T 2 WI (upper row) and ADC map (lower row). A: temporal muscle cauterization alone (group A). Note the lesion with early T2WI hyperintensity and reduced ADC (arrows). B: temporal muscle incision alone (group B). C: temporal muscle incision and craniotomy (group C). D: temporal muscle incision, craniotomy and MCA electrocoagulation. Note the ischemic lesion with low ADC (arrow) and normal T2WI with a limited superficial traumatic lesion (arrow).

Figure 2
figure 2

Impact of temporal muscle cauterization on pMCAO with T 2 WI. A: temporal muscle cauterization alone (group A) showing day 0 traumatic lesion (interrupted lines). B: temporal muscle cauterization, craniotomy and MCA electrocoagulation (group E). Color-coded magnification shows the boundaries of the ischemic lesion (dotted line) and traumatic lesion (interrupted lines) 6 h after pMCAO. C: same mice at day 1 showing the limits of the final lesion (dotted line).


Our results showed that temporal muscle cauterization in the absence of ischemic stimulus produced a hyperintense area on T2WI highly suggestive of traumatic injury. Indeed, T2 increase is not expected in ischemic lesions within the first hours of occlusion in adults, although early T2 increase has been reported in neonates after MCA electrocoagulation [10] or hypoxia-ischaemia [11]. Early mass effect is uncommon after ischaemia in the adult rat [12] or mouse [13]. Acute ADC decrease is not specific of ischemic insult and has been described in both experimental and human traumatic brain injury [14, 15]. Signal suggestive of intra- or extra-cranial surgery-related bleeding (T2 hypointensity) would have been ascertained using T2*WI, but were not noted. No traumatic injury was observed after temporal muscle incision. Accordingly, incision should be preferred over cauterization for temporal muscle dissection.

The MRI appearance of lesions resulting from both temporal muscle cauterization (traumatic damage) and occlusion (ischemic damage) may mimic an infarction, especially if imaging is done at later time points. Histopathological analyses are usually performed after a delay of 24-72 h, when traumatic and ischemic damage may not be discernable, while early histological examination of intracerebral coagulation necrosis would be required to ascertain the thermal origin of traumatic damage induced by muscle cauterization.

In the last decade, high resolution MRI has become a valuable tool for monitoring tissue damage in rodent models of cerebral ischemia. Early MRI monitoring may help to identify non-specific brain injury that could hamper neuroprotective drugs assessment.


  1. Gladstone DJ, Black SE, Hakim AM: Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002, 33: 2123–2136. 10.1161/01.STR.0000025518.34157.51

    Article  PubMed  Google Scholar 

  2. Liu S, Zhen G, Meloni BP, Campbell K, Winn R: Rodent stroke model guidelines for preclinical stroke trials. J Exp Stroke Transl Med 1st edition. 2009, 2: 2–27.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Tamura A, Graham DI, McCulloch J, Teasdale GM: Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981, 1: 53–60.

    Article  CAS  PubMed  Google Scholar 

  4. Welsh FA, Sakamoto T, McKee AE, Sims RE: Effect of lactacidosis on pyridine nucleotide stability during ischemia in mouse brain. J Neurochem 1987, 49: 846–851. 10.1111/j.1471-4159.1987.tb00971.x

    Article  CAS  PubMed  Google Scholar 

  5. Boutin H, Dauphin F, MacKenzie ET, Jauzac P: Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice. Stroke 1999, 30: 1271–1277.

    Article  CAS  PubMed  Google Scholar 

  6. Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, Malfertheiner M, Kohrmann M, Potrovita I, Maegele I, Beyer C, Burke JR, Hasan MT, Bujard H, Wirth T, Pasparakis M, Schwaninger M: IKK mediates ischemia-induced neuronal death. Nat Med 2005, 11: 1322–1329. 10.1038/nm1323

    Article  CAS  PubMed  Google Scholar 

  7. Carmichael ST: Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005, 2: 396–409. 10.1602/neurorx.2.3.396

    Article  PubMed Central  PubMed  Google Scholar 

  8. Durukan A, Tatlisumak T: Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007, 87: 179–197. 10.1016/j.pbb.2007.04.015

    Article  CAS  PubMed  Google Scholar 

  9. Pialat JB, Cho TH, Beuf O, Joye E, Moucharrafie S, Langlois JB, Nemoz C, Janier M, Berthezene Y, Nighoghossian N, Desvergne B, Wiart M: MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice. NMR Biomed 2007, 20: 335–342. 10.1002/nbm.1157

    Article  CAS  PubMed  Google Scholar 

  10. Fau S, Po C, Gillet B, Sizonenko S, Mariani J, Meric P, Charriaut-Marlangue C: Effect of the reperfusion after cerebral ischemia in neonatal rats using MRI monitoring. Exp Neurol 2007, 208: 297–304.

    Article  PubMed  Google Scholar 

  11. Qiao M, Latta P, Meng S, Tomanek B, Tuor UI: Development of acute edema following cerebral hypoxia-ischemia in neonatal compared with juvenile rats using magnetic resonance imaging. Pediatr Res 2004, 55: 101–106. 10.1203/01.PDR.0000100477.59081.FE

    Article  PubMed  Google Scholar 

  12. Rudin M, Baumann D, Ekatodramis D, Stirnimann R, McAllister KH, Sauter A: MRI analysis of the changes in apparent water diffusion coefficient, T(2) relaxation time, and cerebral blood flow and volume in the temporal evolution of cerebral infarction following permanent middle cerebral artery occlusion in rats. Exp Neurol 2001, 169: 56–63. 10.1006/exnr.2001.7650

    Article  CAS  PubMed  Google Scholar 

  13. Barber PA, Hoyte L, Kirk D, Foniok T, Buchan A, Tuor U: Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neurosci Lett 2005, 388: 54–59. 10.1016/j.neulet.2005.06.067

    Article  CAS  PubMed  Google Scholar 

  14. Marmarou A, Signoretti S, Fatouros PP, Portella G, Aygok GA, Bullock MR: Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries. J Neurosurg 2006, 104: 720–730. 10.3171/jns.2006.104.5.720

    Article  PubMed  Google Scholar 

  15. Unterberg AW, Stover J, Kress B, Kiening KL: Edema and brain trauma. Neuroscience 2004, 129: 1021–1029. 10.1016/j.neuroscience.2004.06.046

    Article  CAS  PubMed  Google Scholar 

Download references


We are grateful to Jean-Baptiste Langlois, from the Small Animal Multimodal Imaging Facility, Animage (CERMEP, Lyon, France) for his help in MRI experiments.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Norbert Nighoghossian.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

FC carried out the MRI experiments, participated in the design of the study and helped to draft the manuscript. SM carried out surgery. MW designed and optimized the MRI acquisition protocol, and helped to draft the manuscript. JCB participated in the MRI experiments. YB and NN conceived the study, and participated in its design and coordination. THC conceived the study, participated in its design, performed image analysis, and drafted the manuscript. All authors read and approved the final manuscript.

Fabien Chauveau, Samir Moucharrafie contributed equally to this work.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Chauveau, F., Moucharrafie, S., Wiart, M. et al. In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure. Exp & Trans Stroke Med 2, 4 (2010).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: